Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous NTG for US Radial Artery Cannulation
NCT03006640Completed
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Randomised, triple-blind trial of nitroglycerin (2 arms). Primary endpoint: Success rate. Started Jan 2016; status: completed.
02
Drugs
nitroglycerin
Beyond the preview
Go deeper on NCT03006640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006640.